Synthetic Biology - Publications - Faculty & Research - Harvard Business School

Filter Results: (26)

Filter Results: (26)

Show Results For

Page 1 of 26 Results →

August 2019
Case

Synthetic Biology Investment Opportunity

By: Peter Barrett, Karim R. Lakhani, Julia Kelley and Kerry Herman

Using an overview of the emerging technology of Synthetic Biology, this case provides the basis for discussion on what questions one would ask in evaluating a potential investment in the field. View Details

Keywords: Synthetic Biology; Investment

Awards

Synthetic Biology 3.0 Travel Fellowship

Received a 2007 Synthetic Biology 3.0 Travel Fellowship to present at Synthetic Biology 3.0 in Zurich, Switzerland. View Details

December 2009
Article

Aspects of the Political Economy of Development and Synthetic Biology

By: Rachel Wellhausen and Gautam Mukunda

Keywords: Government and Politics; Economy; Growth and Development; Science

Find at Harvard

Oct 2008
Conference Presentation

The Rumpelstiltskin Effect: Synthetic Biology and International Trade

By: Gautam Mukunda and Rachel Wellhausen

15 Jun 2011 - 17 Jun 2011
Conference Presentation

A multi-disciplinary process for assessing synthetic biology applications

By: Gautam Mukunda, Allen Lin and Kenneth Oye

Keywords: Science

08 May 2015
HBS Seminar

Timothy K. Lu, M.D., PhD. (MIT Synthetic Biology Center, Co-Founder, Synlogic, Inc., Co-Founder, Sample6, Inc., MIT

October 2022 (Revised May 2023)
Case

Ginkgo Bioworks vs. Scorpion Capital: The Debate Over Related-Party Revenues

By: Aiyesha Dey, Jonas Heese, Suraj Srinivasan and Annelena Lobb

Ginkgo Bioworks, a synthetic biology company based in Boston, Massachusetts, faced divergent views on its revenue possibilities and accounting practices. After a report emerged accusing it of fraudulent accounting and lack of innovation, its share price plunged. But... View Details

Keywords: Fraud Allegations; Revenue; Reports; Accounting Audits; Innovation and Management; Investment; Biotechnology Industry; Boston

26 Nov 2012
News

“Indispensable: When Leaders Really Matter”

February 2010
Case

Amyris Biotechnologies: Commercializing Biofuel

By: Gary P. Pisano and Alison Berkley Wagonfeld

In 2009, Amyris Biotechnologies was building a plant in Brazil that used synthetic biology to convert sugarcane into both renewable fuels and renewable chemicals. The Amyris' marketing team was investigating the commercial interest for both types of products, while the... View Details

Keywords: Renewable Energy; Chemicals; Risk Management; Product Marketing; Product Development; Production; Environmental Sustainability; Commercialization; Biotechnology Industry; Brazil

October 2019 (Revised November 2019)
Case

C16 Biosciences: Lab-Grown Palm Oil

By: Jeffrey J. Bussgang and Olivia Hull

Synthetic biology start-up C16 Biosciences wants to solve a big problem: replace palm oil, a major contributor to deforestation and climate change, with a lab-grown substitute. CEO Shara Ticku has ambitious plans to supply her lab-grown palm oil to food manufacturers,... View Details

Keywords: Science-Based Business; Environmental Sustainability; Social Entrepreneurship; Product Development; Product Positioning; Venture Capital; Strategy; Decision Making; Food and Beverage Industry; Consumer Products Industry

Web

Curriculum - MBA

research. This will include human disease modeling, identifying drugs that target endogenous stem cells or otherwise promote tissue repair, and regenerative medicine (cell-based therapies). Systems Biology View Details

Web

Live from Klarman Hall - Alumni

next decade — AI, Blockchain and Synthetic Biology — and examine their impact on who we are as individuals and as a species. 2024 Spring Reunions—May 30-June 2, 2024 During the 2024 Spring Reunions on May 31... View Details

14 Jul 2023
Blog Post

Harvard Business School Announces Its 2023-2024 Blavatnik Fellows

synthetic biology and data science company that’s digitizing taste and smell. Morgan previously ran business development and fundraising at Trellis Bioscience, a clinical-stage Series C startup developing... View Details

06 Sep 2022
Blog Post

Student Spotlight: Summer Internships in Business & Environment

Foods is a cultivated meat company using synthetic biology to create the next generation of meat alternatives that use cell-based ingredients in combination with plant-based meat, enabling the creation of... View Details

Web

2022 Reunion Presentations - Alumni

technology.” We will examine 5 recently developed “godlike technologies” that have passed commercial viability and are on track to change the foundations of business and society by 2032—AI, blockchain, ubiquitous networks, synthetic... View Details

Web

3 Technologies that Will Change the World in the Next Decade - Course Catalog

be and Art Blocks a company that is redefining digital art and creating a way for artists to capture value from their art. Synthetic Biology – Enabling us to reprogram DNA and rewrite the code of life (25%... View Details

Web

2024 Reunion Presentations - Alumni

‘godlike technologies’ that have passed commercial viability and are on- track to change the foundations of business and society in the next decade – AI, Blockchain and Synthetic Biology and examine their... View Details

Profile

Rye Barcott

Rye says. "But they discovered that their synthetic biology processes could be used to create fuels. Now they are a for-profit energy company with a nonprofit subsidiary that makes anti-malarial drugs.... View Details

01 Jan 2008
News

John Doerr, MBA 1976

a dramatic impact on life in the 21st century, from online retail giant Amazon.com to Internet behemoth Google to synthetic biology leader Amyris. Doerr has become a leading advocate of innovation and... View Details

11 May 2010
First Look

First Look: May 11

Amyris Biotechnologies: Commercializing Biofuel Gary P. Pisano and Alison Berkley WagonfeldHarvard Business School Case 610-031 In 2009, Amyris Biotechnologies was building a plant in Brazil that used synthetic View Details

Keywords: Martha Lagace

1
2
→